Assessment of the Effect of Age on Duration of Analgesia From Single-shot Femoral Nerve Blocks
1 other identifier
observational
100
1 country
1
Brief Summary
Cohort study to examine the effect of age on duration of analgesia in patients receiving single-shot femoral nerve block prior to surgery, by postoperative phone follow-up questionnaire.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2020
CompletedFirst Submitted
Initial submission to the registry
July 27, 2020
CompletedFirst Posted
Study publicly available on registry
July 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2022
CompletedSeptember 10, 2021
September 1, 2021
2 years
July 27, 2020
September 8, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Duration of analgesia
Total duration of analgesia from peripheral femoral nerve block
From time of block placement to patient to the reported end of analgesic effect, up to 72 hours
Eligibility Criteria
Adult ambulatory surgery patients receiving a single-shot peripheral femoral nerve block preoperatively as part of their clinical anesthesia care on day-of-surgery.
You may qualify if:
- Adult patients (age \>18 years)
- American Society of Anesthesiology physical status 1-3
- Having ambulatory surgery, who have received a single-shot femoral nerve block
- Able to read and understand English
- Have access to a phone after surgery
You may not qualify if:
- Pediatric patients (age \<18 years)
- American Society of Anesthesiology physical status \>3
- Unable to read and understand English
- Unable to have access to a phone after surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Washington Medical Center
Seattle, Washington, 98195, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vanessa J Loland, MD
University of Washington
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, School of Medicine
Study Record Dates
First Submitted
July 27, 2020
First Posted
July 31, 2020
Study Start
June 15, 2020
Primary Completion
June 15, 2022
Study Completion
June 15, 2022
Last Updated
September 10, 2021
Record last verified: 2021-09